Meet Ottava, J&J’s surgical robot leading the healthcare giant into a lucrative new market
Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…
Johnson & Johnson Stock Jumps 3% as Healthcare Rotation Lifts Shares
This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ), the healthcare heavyweight behind blockbuster medicines and medical…
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo…
Johnson & Johnson (JNJ) Could Be 10% Overvalued Following Leadership Change
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Johnson & Johnson baby powder lawsuit: J&J offers $5.5 billion to settle 76,000 cancer claims
Johnson & Johnson (J&J) has agreed to pay an estimated $5.5 billion to settle tens of thousands of…
How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)
Quick Read Generating $108,000 annually from dividends requires roughly $2.7M at a 4% yield, $1.8M at 6%, or…
Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7%…
US pharmaceutical giant Johnson & Johnson to pay out $7.9 billion over baby powder lawsuit
US pharmaceutical company Johnson & Johnson (J&J) has said it will pay an estimated $US5.5 billion ($7.9 billion)…
J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.
Intuitive Surgical Inc location sign-by Sundry Photography via iStock Intuitive Surgical (ISRG) shares closed lower on July 22…
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories
Quick Read JNJ’s 64-year dividend streak and oncology momentum make it the steadier buy, while ABT’s 18x forward…
Why Is The Market Punishing JNJ Stock?
The pharma division is firing on all cylinders, but a sudden crack in the MedTech business has the…
Johnson & Johnson (JNJ) Q2 earnings
Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from…